The beneficial effects of rTs-gal on colitis may be achieved by controlling the intestinal flora and bacterial functions, which may reduce the generation of LPS and suppress the expression of TLR4, MyD88, and NF-κB. The gene discussed is MYD88; the disease is colitis.